Skip to main content

29 January 2022

Last updated: Wednesday 26 January 2022

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

JAK2 inhibitors: a breakthrough in oncology?

Thursday 23 September 2010

Interviewee/Contributor

Jürg Eckhardt

Organisation

Bellevue Asset Management

Organisations

Scancell Holdings Plc
European Medicines Agency
Altheia Science Srl
Novasecta Ltd
Janssen Oncology
ThromboGenics NV
Araris Biotech AG
Wellcome Trust
Transgene SA
European Patent Office

Interviewees and Contributers

Simon Kerry
Patricia Hurley
Antonin de Fougerolles
Gabriele Schaffner-Dallmann
Vincent Charlon
Paul Thompson
Andrea van Elsas
Greg Mullen
Achim Plum
Angelika Joos

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Anders Tullgren joins BerGenBio

Thursday 13 January 2022

BiVictriX Therapeutics appoints CFO

Thursday 13 January 2022

Faron appoints new CMO

Thursday 13 January 2022

MiNA Therapeutics appoints directors

Thursday 13 January 2022

Agomab expands leadership team

Thursday 13 January 2022

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2022 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form